/
ACBM
$0.03+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.02 – $0.10
5% from low
Exchange
OTC Link
CS
Price (6 mo)
Loading chart…
Change$-4.74
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.0M | $193.5K | $688.0K | $1.2M | $658.5K | $0 | $0 | $0 |
| Cost of revenue | $7.2M | $181.4K | $528.6K | $938.0K | $518.0K | $0 | $0 | $0 |
| Gross profit | $833.4K | $12.1K | $159.4K | $259.5K | $140.5K | $0 | $0 | $0 |
| Gross margin | 10.4% | 6.3% | 23.2% | 21.7% | 21.3% | — | — | — |
| R&D | $0 | $0 | $0 | $5.3M | $10.1M | $4.8M | $0 | $0 |
| Operating income | $515.5K | −$422.8K | −$130.5K | −$7.7M | −$15.9M | −$8.8M | −$38.0K | −$154.0K |
| EBITDA | $515.5K | −$301.7K | $0 | $0 | −$15.9M | $0 | −$38.0K | −$154.0K |
| Net income | $419.7K | −$371.6K | −$117.5K | −$7.7M | −$15.9M | −$8.8M | −$42.3K | −$101.1K |
| Net margin | 5.2% | -192.0% | -17.1% | -643.2% | -2410.2% | — | — | — |
| EPS (diluted) | 0.01 | -0.01 | -0.00 | -0.14 | -0.26 | -0.15 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
Peer comparison
ARCO BIOMEDICAL CO LTD
ARCO BIOMEDICAL CO LTD
Held by traders on TradeandTell
No one on the platform currently holds ACBM.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ACBM as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2017-05-22 | 3-for-1 |
| 2008-05-23 | 2-for-1 |
Recent trades on TradeandTell
No one on the platform has traded ACBM yet.